Moore Capital Management, LP Aravive, Inc. Transaction History
Moore Capital Management, LP
- $5.98 Billion
- Q1 2024
A detailed history of Moore Capital Management, LP transactions in Aravive, Inc. stock. As of the latest transaction made, Moore Capital Management, LP holds 100,000 shares of ARAV stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100,000Holding current value
$0% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ARAV
# of Institutions
4Shares Held
1.9MCall Options Held
0Put Options Held
0About Aravive, Inc.
- Ticker ARAV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,518,300
- Description
- Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...